Abstract:Background: Secondary infection is an important factor affecting mortality and quality of life in patients with severe acute pancreatitis. The characteristics of secondary infection, which are well known to clinicians, need to be re-examined in detail, and their understanding among clinicians needs to be updated accordingly. Aim: This study aims to investigate the characteristics and drug resistance of pathogens causing severe acute pancreatitis (SAP) secondary infection, to objectively present infection situation, and to provide reference for improved clinical management. Methods: A retrospective analysis was performed on 55 consecutive patients with SAP who developed secondary infection with an accurate evidence of bacterial/fungal culture from 2016 to 2018. The statistics included the spectrum and distribution of pathogens, the drug resistance of main pathogens, and associations between multiple infectious parameters and mortality. Results: A total of 181 strains of pathogens were isolated from (peri)pancreas; bloodstream; and respiratory, urinary, and biliary systems in 55 patients. The strains included 98 g-negative bacteria, 58 g-positive bacteria, and 25 fungi. Bloodstream infection (36.5%) was the most frequent infectious complication, followed by (peri)pancreatic infection (32.0%). Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli, and Stenotrophomonas maltophilia were predominant among gram-negative bacteria. Gram-positive bacterial infections were mainly caused by Enterococcus faecium and Staphylococcus spp. Fungal infections were predominantly caused by Candida spp. The drug resistance of pathogens causing SAP secondary infection was generally higher than the surveillance level. Patients in the death group were older (55 ± 13 years vs. 46 ± 14 years; p = 0.039) and had longer intensive care unit (ICU) stay (14 vs. 8; p = 0.026) than those in the survival group. A. baumannii infection (68.4% vs. 33%; p = 0.013), number of pathogens ≥ 4 (10 vs. 6; p = 0.005), pancreatic infection (14 vs. 15, p = 0.024), and urinary infection (8 vs. 5; p = 0.019) were significantly associated with mortality. Conclusion: Gram-negative bacteria are the main pathogens causing SAP secondary infection, in which nosocomial infections play a major role. The drug resistance profile of gram-negative bacteria is seriously threatening, and the commonly used antibiotics in SAP are gradually losing their effectiveness. Much attention should be paid to the rational use of antibiotics, and strategies should be established for infection prevention in SAP.

Risk Factors of Secondary Pancreatic Infection in Patients with Severe Acute Pancreatitis

Risk factors and drug resistance analysis of multi-drug resistance Pseudomonas aeruginosa infection in severe acute pancreatitis*

Factors Associated with Pancreatic Infection in Patients with Severe Acute Pancreatisis.

The Risk Factors Analysis of Earlier Pancreatic Infection in Severe Acute Pancreatitis

Predisposing factors to infection secondary to severe acute pancreatitis: an analysis of 42 cases

The Predisposing Factors Study of Pancreatic Infection in Severe Acute Pancreatitis

Prevention and Treatment of Secondary Infection in Patients with Severe Acute Pancreatitis: 310 Cases Analysis

Factors predisposing to severe acute pancreatitis: evaluation and prevention

Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital

Early infection in patients with severe acute pancreatitis

Clinical Investigation of Severe Acute Pancreatitis Complicated with Infection

Study on the Risk Factors of Fungal Infection in Severe Acute Pancreatitis.

Risk Factors for Death in Patients with Severe Acute Pancreatitis in Guizhou Province, China

CLINICAL ANALYSIS OF ABDOMINAL INFECTION SECONDARY TO ACUTE SEVERE PANCREATITIS

Effects of Intestinal Barrier Function Protection on Prognosis of Patients with Severe Acute Pancreatitis

Characteristics and risk factors for extrapancreatic infection in patients with moderate or severe acute pancreatitis

Infectious Complications in Patients with Severe Acute Pancreatitis

Postoperative Complications and Mortality in Patients with Severe Acute Pancreatitis

The prophylaxis and treatment of pancreatic infection in severe acute pancreatitis

Risk Factors Of Multi-Drug Resistant Pathogens Induced Infection In Severe Acute Pancreatitis

Risk Factors Influencing Mortality of Patients with Severe Acute Pancreatitis Within 24 Hours after Admission.